Tori Strong

Array ( [id] => 9882811 [patent_doc_number] => 08969576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Substituted N-aryl pyridinones' [patent_app_type] => utility [patent_app_number] => 14/455339 [patent_app_country] => US [patent_app_date] => 2014-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21831 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14455339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14945669 [patent_doc_number] => 10434079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-08 [patent_title] => Compositions and methods for the treatment of fatty acid metabolism disorders [patent_app_type] => utility [patent_app_number] => 14/907397 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 9259 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053259 [patent_doc_number] => 20160250221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'INHIBITORS OF FAPP2 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/907172 [patent_app_country] => US [patent_app_date] => 2014-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 27787 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14085499 [patent_doc_number] => 10238629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Methods for reducing the occurrence of hot flashes [patent_app_type] => utility [patent_app_number] => 14/906695 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 3897 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14906695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10782861 [patent_doc_number] => 20160129017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'SHIP INHIBITION TO COMBAT OBESITY' [patent_app_type] => utility [patent_app_number] => 14/900719 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 33482 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14731329 [patent_doc_number] => 10385054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases [patent_app_type] => utility [patent_app_number] => 14/392214 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5076 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10806468 [patent_doc_number] => 20160152626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/900209 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53818 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11348887 [patent_doc_number] => 20160367627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'ANTI-TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 14/901929 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15355 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799066 [patent_doc_number] => 20160145223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'Bicyclyl-Substituted Isothiazoline Compounds' [patent_app_type] => utility [patent_app_number] => 14/900210 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87462 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13916525 [patent_doc_number] => 10202370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-12 [patent_title] => Benzimidazole derivatives as selective proteine kinase inhibitors [patent_app_type] => utility [patent_app_number] => 14/900008 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16567 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10906295 [patent_doc_number] => 20140309307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'Branched 3-phenylpropionic acid derivatives and their use' [patent_app_type] => utility [patent_app_number] => 14/304171 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43031 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14304171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772640 [patent_doc_number] => 20140296303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Use of Pyridoxamine to Treat and/or Prevent Disease Processes' [patent_app_type] => utility [patent_app_number] => 14/302968 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769014 [patent_doc_number] => 20160115171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => '4-AMINO-6-PHENYL-5,6-DIHYDROIMIDAZO[1,5-A]PYRAZIN-3(2H)-ONE DERIVATIVES AS INHIBITORS OF BETA-SECRETASE (BACE)' [patent_app_type] => utility [patent_app_number] => 14/897420 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18560 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750279 [patent_doc_number] => 09708282 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-07-18 [patent_title] => 'Anti-inflammatory and antiepileptic neuroprotective statin compounds' [patent_app_type] => utility [patent_app_number] => 14/896315 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9899 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044390 [patent_doc_number] => 09084773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Small molecule antagonists of bacterial quorum-sensing receptors' [patent_app_type] => utility [patent_app_number] => 14/288984 [patent_app_country] => US [patent_app_date] => 2014-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 10114 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14288984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521524 [patent_doc_number] => 09604910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation' [patent_app_type] => utility [patent_app_number] => 14/287735 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 4206 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784132 [patent_doc_number] => 20160130288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'OXAZOLIDINONE-QUINOLONE HYBRID ANTIBACTERIALS FOR THE PARENTERAL TREATMENT OR PROPHYLAXIS OF BACTERIAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/894400 [patent_app_country] => US [patent_app_date] => 2014-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11118 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019530 [patent_doc_number] => 09062001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Substituted N-aryl pyridinones' [patent_app_type] => utility [patent_app_number] => 14/266048 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21811 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14266048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10728219 [patent_doc_number] => 20160074367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'AMYLOID PRECURSOR PROTEIN MRNA BLOCKERS FOR TREATING DOWN SYDNROME AND ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/787873 [patent_app_country] => US [patent_app_date] => 2014-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29969 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191440 [patent_doc_number] => 09422239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-08-23 [patent_title] => 'Dual PPAR-δ PPAR-γ agonists' [patent_app_type] => utility [patent_app_number] => 14/212864 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17089 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212864 [rel_patent_id] =>[rel_patent_doc_number] =>)